How do Kikuchi-Fujimoto disease (KFD) and Castleman disease differ in terms of presentation, pathology, and treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Kikuchi-Fujimoto Disease vs Castleman Disease: Key Differentiating Features

Kikuchi-Fujimoto disease (KFD) and Castleman disease are distinct lymphoproliferative disorders that differ fundamentally in their pathogenesis, clinical presentation, histopathology, and treatment approaches.

Clinical Presentation

Kikuchi-Fujimoto Disease

KFD predominantly affects young adults aged 20-35 years with female predominance, particularly those of Asian descent 1, 2. The hallmark presentation includes:

  • Painful cervical lymphadenopathy (most commonly posterior cervical)
  • High-grade fever (often >39°C, remittent pattern)
  • Constitutional symptoms: marked fatigue, night sweats, weight loss
  • Self-limited course: typically resolves spontaneously within 1-4 months
  • Laboratory findings show leukopenia (not leukocytosis), elevated inflammatory markers, and mild anemia 3, 4

Castleman Disease (HHV-8 associated MCD)

Castleman disease, particularly the multicentric form associated with HIV, presents differently:

  • Occurs mainly in HIV-positive patients (even with undetectable viral loads)
  • Systemic symptoms from cytokine storm: fever, night sweats
  • Generalized lymphadenopathy (not limited to cervical region)
  • Splenomegaly is common (notably absent in KFD)
  • Severe complications: hemophagocytic syndrome, concurrent Kaposi sarcoma
  • Laboratory shows elevated HHV-8 viral load, IL-6, IL-10, and C-reactive protein 5

Pathological Differences

KFD Histopathology

The diagnosis requires excisional lymph node biopsy showing 1, 3, 2:

  • Geographic/patchy coagulation necrosis with karyorrhectic debris
  • Paracortical expansion with proliferation of histiocytes and plasmacytoid dendritic cells
  • CD8+ T cell predominance
  • Absence of neutrophils (critical distinguishing feature)
  • No evidence of malignancy on flow cytometry/immunohistochemistry

Castleman Disease Histopathology

  • Lymph node architecture shows characteristic patterns (hyaline-vascular or plasmacytic variants)
  • HHV-8 positivity in HIV-associated MCD
  • Vascular proliferation and plasma cell infiltration
  • No necrotizing features typical of KFD

Treatment Approaches

KFD Management

KFD is self-limiting and requires primarily supportive care 1, 6, 4:

  • NSAIDs for symptomatic relief of fever and pain
  • Short-course corticosteroids for severe symptoms (not routinely needed)
  • Hydroxychloroquine may be considered in steroid-dependent or relapsing cases 6, 2
  • No antibiotics or chemotherapy indicated
  • Monitor for autoimmune disease development, particularly systemic lupus erythematosus (10-20% association) 2

Castleman Disease Management

Requires aggressive immunotherapy-based treatment 5:

  • Rituximab is first-line therapy (375 mg/m² weekly × 4-8 doses)
  • Optimize antiretroviral therapy in HIV-positive patients
  • Add etoposide to rituximab in severe cases or cytokine storm
  • Liposomal doxorubicin + rituximab if concurrent Kaposi sarcoma present
  • Rechallenges with rituximab are safe and effective for relapses

Critical Diagnostic Pitfalls

When Suspecting KFD:

  • Do not mistake for lymphoma: Up to one-third of KFD cases are initially misdiagnosed as malignant lymphoma 2
  • Do not treat empirically with antibiotics: Failure to respond to antibiotics in febrile lymphadenopathy should raise suspicion for KFD 3, 4
  • Do not perform only fine-needle aspiration: Excisional biopsy is mandatory for definitive diagnosis
  • Screen for tuberculosis and lymphoma first, but consider KFD when these are negative 7

When Suspecting Castleman Disease:

  • Check HIV status and HHV-8 viral load immediately
  • Look for splenomegaly on imaging (present in Castleman, absent in KFD)
  • Assess for concurrent Kaposi sarcoma (common in HHV-8-MCD)
  • Measure IL-6 and IL-10 levels (markedly elevated in Castleman, normal in KFD)

Prognosis and Follow-up

KFD: Excellent prognosis with spontaneous resolution. Recurrence occurs in <5% of cases, sometimes after years 6. Long-term rheumatologic follow-up is essential due to SLE association 2.

Castleman Disease: Requires ongoing monitoring for relapse, NHL development (especially PEL and DLBCL), and KS progression. Clinical follow-up every 3-6 months is recommended 5.

Algorithmic Approach to Differentiation

Step 1: Check HIV status and HHV-8 serology

  • Positive → Consider Castleman disease

Step 2: Assess lymphadenopathy distribution

  • Localized cervical → Favor KFD
  • Generalized with splenomegaly → Favor Castleman

Step 3: Laboratory pattern

  • Leukopenia → Favor KFD
  • Elevated IL-6/IL-10/HHV-8 VL → Favor Castleman

Step 4: Excisional biopsy

  • Necrotizing histiocytic lymphadenitis without neutrophils → KFD
  • HHV-8+ with vascular/plasmacytic features → Castleman

References

2
Research

Pathogenesis, diagnosis, and management of Kikuchi-Fujimoto disease.

Cancer control : journal of the Moffitt Cancer Center, 2014

Related Questions

What is Kikuchi disease, including its definition, clinical presentation, diagnosis, and treatment options?
What is the recommended steroid dosing regimen for an adult with severe Kikuchi disease (histiocytic necrotizing lymphadenitis)?
In a pediatric patient with enlarged cervical lymph node swelling, fever, intermittent weight loss, and anemia, what is the best diagnostic step?
What diagnostic workup is recommended for a 20-year-old male with unexplained lymphadenopathy?
What are the differential diagnoses and recommended work‑up for a 16‑year‑old male with a two‑week history of intermittent fever, an initial four‑day episode of vomiting, chills, intermittent dry headache, cough, three‑day edema and erythema of the hands and feet, and a forearm rash, now febrile?
What is the recommended anesthetic technique and management for a patient with extrahepatic portal venous obstruction undergoing a meso‑Rex shunt?
In hepatic encephalopathy, what is the role of administering lactulose enema in addition to oral lactulose syrup?
Does glucagon help dislodge a soft food bolus lodged in the esophagus?
What is the appropriate evaluation and management of a necrotic lymph node?
What is the recommended acute management for a newborn diagnosed with transposition of the great arteries (TGA)?
How should a vegan woman with uterine fibroids be managed, including dietary recommendations, monitoring of iron, vitamin D and vitamin B12 status, and appropriate medical or surgical therapies?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.